Cargando…

Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro

Microalgae, eukaryotic unicellular plants, are increasing in demand due to their use as nutraceutical and food supplements. They consisted different kinds of biologically active components such as polysaccharides. On the other hand, cancer is the leading cause of death globally. At present, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shengfeng, Wan, Haitao, Wang, Rui, Hao, Daijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385690/
https://www.ncbi.nlm.nih.gov/pubmed/30809437
http://dx.doi.org/10.7717/peerj.6409
_version_ 1783397257166454784
author Yang, Shengfeng
Wan, Haitao
Wang, Rui
Hao, Daijun
author_facet Yang, Shengfeng
Wan, Haitao
Wang, Rui
Hao, Daijun
author_sort Yang, Shengfeng
collection PubMed
description Microalgae, eukaryotic unicellular plants, are increasing in demand due to their use as nutraceutical and food supplements. They consisted different kinds of biologically active components such as polysaccharides. On the other hand, cancer is the leading cause of death globally. At present, there is no efficient method to cure it. Therefore, in this work, we extracted polysaccharides from Phaeodactylum tricornutum (PTP), characterized the chemical composition and structure, and investigated its anticancer activity on HepG2 cells. The results showed that PTP was a sulfated polysaccharide with a high Mw of 4,810 kDa, and xylose, fucose, glucose and galactose were the main monosaccharides. PTP has significant anticancer activity in a dose-dependent manner (up to 60.37% at 250 ug/mL) according to MTT assays. Furthermore, cycle analysis was carried out to explain its anticancer activity. The results showed that it exhibited anticancer effect mainly through the induction of apoptosis without affecting the cycle and mitosis of HepG2 cells. This might make it a potential drug for anticancer treatment in the future.
format Online
Article
Text
id pubmed-6385690
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-63856902019-02-26 Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro Yang, Shengfeng Wan, Haitao Wang, Rui Hao, Daijun PeerJ Biochemistry Microalgae, eukaryotic unicellular plants, are increasing in demand due to their use as nutraceutical and food supplements. They consisted different kinds of biologically active components such as polysaccharides. On the other hand, cancer is the leading cause of death globally. At present, there is no efficient method to cure it. Therefore, in this work, we extracted polysaccharides from Phaeodactylum tricornutum (PTP), characterized the chemical composition and structure, and investigated its anticancer activity on HepG2 cells. The results showed that PTP was a sulfated polysaccharide with a high Mw of 4,810 kDa, and xylose, fucose, glucose and galactose were the main monosaccharides. PTP has significant anticancer activity in a dose-dependent manner (up to 60.37% at 250 ug/mL) according to MTT assays. Furthermore, cycle analysis was carried out to explain its anticancer activity. The results showed that it exhibited anticancer effect mainly through the induction of apoptosis without affecting the cycle and mitosis of HepG2 cells. This might make it a potential drug for anticancer treatment in the future. PeerJ Inc. 2019-02-19 /pmc/articles/PMC6385690/ /pubmed/30809437 http://dx.doi.org/10.7717/peerj.6409 Text en © 2019 Yang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Biochemistry
Yang, Shengfeng
Wan, Haitao
Wang, Rui
Hao, Daijun
Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title_full Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title_fullStr Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title_full_unstemmed Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title_short Sulfated polysaccharides from Phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting HepG2 growth activity in vitro
title_sort sulfated polysaccharides from phaeodactylum tricornutum: isolation, structural characteristics, and inhibiting hepg2 growth activity in vitro
topic Biochemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385690/
https://www.ncbi.nlm.nih.gov/pubmed/30809437
http://dx.doi.org/10.7717/peerj.6409
work_keys_str_mv AT yangshengfeng sulfatedpolysaccharidesfromphaeodactylumtricornutumisolationstructuralcharacteristicsandinhibitinghepg2growthactivityinvitro
AT wanhaitao sulfatedpolysaccharidesfromphaeodactylumtricornutumisolationstructuralcharacteristicsandinhibitinghepg2growthactivityinvitro
AT wangrui sulfatedpolysaccharidesfromphaeodactylumtricornutumisolationstructuralcharacteristicsandinhibitinghepg2growthactivityinvitro
AT haodaijun sulfatedpolysaccharidesfromphaeodactylumtricornutumisolationstructuralcharacteristicsandinhibitinghepg2growthactivityinvitro